Matthew L. Sherman, EVP & Chief Medical Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 5,318 shares at $33.17 ($176K) on 2021-10-04, disclosed to the SEC on 2021-10-06.
Open-market sale of $176k DCPH by EVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.17 | 2,659 | $88K | 50.0% |
| 2 | $33.17 | 2,659 | $88K | 50.0% |
| Total | $33.17 avg | 5,318 | $176K | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |